Anthony Opipari
Förmögenhet: 183 949 $ per 2026-08-31
Förmögenhet: 183 949 $ per 2026-08-31
Anthony Opipari was the founder of First Wave Bio, Inc., founded in 2021, IFM Therapeutics LLC, founded in 2021, and Lycera Corp., founded in 2006 where Dr. Opipari held the title of Senior Director-Biology from 2006 to 2021.
Dr. Opipari currently holds the position of Chief Medical Officer & EVP-Translational Medicine at Odyssey Therapeutics, Inc. since 2024.
Dr. Opipari earned a doctorate degree from the University of Michigan.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
| 2026-05-11 | 7 502 ( 0,02 % ) | 183 949 $ | 2026-08-31 |
| Företag | Position | Start |
|---|---|---|
| ODYSSEY THERAPEUTICS, INC. | Teknisk/Vetenskaplig/F&U Direktör | 2021-04-01 |
| Företag | Position | Slut |
|---|---|---|
Lycera Corp.
Lycera Corp. Pharmaceuticals: MajorHealth Technology Develops novel oral medicines for treating autoimmune diseases and cancer | Grundare | 2021-01-01 |
IFM Therapeutics LLC
IFM Therapeutics LLC Pharmaceuticals: MajorHealth Technology Discovers and develops small molecules that modulate novel targets in the innate immune system as next generation therapies for cancer, autoimmunity and inflammatory disorders | Grundare | - |
First Wave Bio, Inc.
First Wave Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Develops novel therapeutics for the treatment of inflammatory bowel disease | Grundare | - |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 5 |
|---|---|
Lycera Corp.
Lycera Corp. Pharmaceuticals: MajorHealth Technology Develops novel oral medicines for treating autoimmune diseases and cancer | Health Technology |
University of Michigan
University of Michigan Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
IFM Therapeutics LLC
IFM Therapeutics LLC Pharmaceuticals: MajorHealth Technology Discovers and develops small molecules that modulate novel targets in the innate immune system as next generation therapies for cancer, autoimmunity and inflammatory disorders | Health Technology |
First Wave Bio, Inc.
First Wave Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Develops novel therapeutics for the treatment of inflammatory bowel disease | Commercial Services |
Odyssey Therapeutics, Inc.
Odyssey Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops therapeutics for autoimmune and inflammatory diseases | Health Technology |
Välj din utgåva
All finansiell information anpassad till den nationella nivån